Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Golden Matrix Group to Announce Second Quarter Financial Results on August 13th
-
HYLA Successfully Completes Major Order Delivery in Italy
-
Rumble's Founder and CEO Chris Pavlovski to Hold a Post-Earnings Live Stream with Matt Kohrs via Rumble Studio
-
Oxford Lane Capital Corp. Provides July Net Asset Value Update
-
Palisade Bio Selects Dose for Upcoming Phase 1 Clinical Study of PALI-2108 for Ulcerative Colitis
-
Crown LNG Appoints Andrew Judson as Chairman of the Board
-
Vera Therapeutics Provides Business Update and Reports Second Quarter 2024 Financial Results
-
Beavers Wealth Universe Announces One Kitchen Restaurant Opening Inside Walmart and Partnership with Richtech Robotics
-
Verizon Innovative Learning brings esports to classrooms for back to school
-
Mobile-health Network Solutions to Present at Sidoti Virtual Investor Conference August 14-15
-
red violet to Participate in the Midwest IDEAS Investor Conference
-
Breckenridge Distillery Partners with Denver Broncos Legends to Release Fourth Edition Broncos Country Bourbon Blends
-
Anticipating Future Fed Interest Rate Cuts, Consumers Continue to Use Existing Credit, Gain Access to New Lines
-
Prime Medicine Reports Second Quarter 2024 Financial Results and Provides Business Updates
-
GCM Grosvenor Reports Second Quarter 2024 Earnings Results
-
PDS Biotech Announces Abstract Accepted for Oral Presentation at 2024 ASTRO Annual Meeting
-
RAPT Therapeutics Reports Second Quarter 2024 Financial Results
-
Fractyl Health Announces Clinical Results from German Real-World Registry Showing Meaningful and Sustained Weight Loss for at Least One Year After a Single Revita® Endoscopic Procedure
-
KALA BIO to Present at H.C. Wainwright 4th Annual Ophthalmology Virtual Conference
-
Airgain to Present at the 2024 Gateway Conference on September 5th
-
Disc Medicine Reports Second Quarter 2024 Financial Results and Provides Business Update
-
Arq to Attend Upcoming Investor Conferences
-
Veriff Report Highlights Deepfake Threats and Protective Strategies
-
Meineke Selects Katapult’s Innovative Lease-to-Own Solution
-
Evaxion to Present One-Year Clinical Efficacy Data from its Phase 2 Study on Lead Cancer Vaccine Candidate, EVX-01, at the ESMO Congress 2024 in September
-
Acorn’s Q2’24 EPS Improves to $0.11 vs. $0.04 on Revenue Increase in Remote Monitoring and Control Solutions for Backup Power Generators
-
illumin Reports Second Quarter 2024 Financial Results
-
KH Group’s Half-Year Report 2024 publication and webcast
-
Finland-based Quantlytica raises €1 million to launch AI-powered liquidity distribution protocol
-
North Media Q2 2024 Interim Report: Invitation to investor webcast
-
Recursion and Exscientia Enter Definitive Agreement to Create a Global Technology-Enabled Drug Discovery Leader with End-to-End Capabilities
-
Bombardier Partners with Alinghi Red Bull Racing, Uniting Sky and Sea
-
Form 8.3 - Keywords Studios plc - Octopus Investments
-
Knight Therapeutics Reports Second Quarter 2024
-
Base Carbon Announces Receipt of US$11.2 Million From Sale of Carbon Credits
-
Parker Reports Fiscal 2024 Fourth Quarter and Full Year Results and Issues Guidance for Fiscal 2025
-
NuVista Energy LTD. Announces Positive Second Quarter 2024 Financial and Operating Results
-
Recursion Provides Business Updates and Reports Second Quarter 2024 Financial Results
-
Kelly Reports Second-Quarter 2024 Earnings
-
Orezone Closes C$64.9 Million Non-Brokered Private Placement
-
Koryx Copper Intersects 72 METERS at 0.38% CuEq; 80 Meters at 0.34% CuEq, Extending Limits of Mineralization at Haib Copper Project, Southern Namibia
-
Plus Therapeutics to Announce Second Quarter Financial Results and Host Conference Call on August 14, 2024
-
Kura Oncology Announces FDA Clearance of IND Application for Menin Inhibitor Ziftomenib in Advanced Gastrointestinal Stromal Tumors (GIST)
-
Intellia Therapeutics Announces Second Quarter 2024 Financial Results and Highlights Recent Company Progress
-
InflaRx Reports Second Quarter 2024 Financial Results and Provides Business Update
-
Wave Life Sciences Reports Second Quarter 2024 Financial Results and Provides Business Update
-
Cronos Group Reports 2024 Second Quarter Results
-
Tourmaline Bio Reports Second Quarter 2024 Financial Results and Recent Business Highlights
-
Century Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Updates
-
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
